Job Description

About AstraZeneca

AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies.


The Oncology Clinical Research Associate (CRA) has local responsibility for the delivery of the oncology


studies (recruitment and quality data collection) at allocated sites and is an active participant in the local


study team(s). The CRA works in close collaboration with other CRAs and the Local Study Team/ Local


Study Manager to ensure that study commitments are achieved in a timely and efficient manner. The


CRA acts as the main contact with the PI and co-PI, and the overall study site staff and has the


responsibility for monitoring the study conduct to ensure proper delivery of the study.


The CRA is responsible for the preparation, initiation, monitoring and closure of assigned sites in clinical


studies, in compliance with AZ Procedural Documents, international guidelines such as ICH-GCP, and


relevant local regulations and that the sites deliver according to their respective commitment in the


individual studies.


A CRA with longer tenure and experience may take on additional responsibilities that include additional


tasks associated with Local Study Associate Director.


CRAs might have different internal titles based on the experience level (Associate CRA, CRA, Senior CRA).


The experience level depends on the years of experience, performance record, level of independence in


the role, ability to take on additional tasks or tutor more junior colleagues. The SMM Country Head may


assign this internal title after confirmation with Cluster Director SMM/Senior Director SMM (Region). This


will only be applicable for countries which have been exempted to use tiered internal titles.

Typical Accountabilities

Contributes to the selection of potential investigators.

In some countries, as required, CRAs are accountable for study start-up and regulatory maintenance.

Tasks may include Site Qualification Visits, collection, preparation, review and tracking of documents


for the application process; submission of proper application/documents to EC/IRB and to Regulatory


Authorities for start-up and for the duration of the study.

Trains, supports and advises Investigators and site staff in study related matters, including Risk Based

Quality Management (RbQM) principles.

Confirms that site staff have completed and documented the required trainings appropriately,

including ICH-GCP training, prior to and for the duration of the study. Ensures the sites are


inspection ready at all times.


Actively participates in Local Study Team (LST) meetings. Contributes to National Investigators meetings, as applicable. Initiates, monitors and closes study sites in compliance with AZ Procedural Documents. Shares information on patient recruitment and study site progress (site quality/performance) within the LST. Drives performance at the sites. Proactively identifies and ensures timely resolution to study-related issues and escalates them as appropriate. Updates CTMS and other systems with data from study sites as per required timelines. Manages study supplies (ISF, etc), drug supplies and drug accountability at study site. Prepares study drug for destruction, if applicable. Performs monitoring visits (remote and onsite), as well as remote data checks, in accordance with the timelines specified in the study specific Monitoring Plan. If required, determines and discusses with LSM the correct timing and type of visits. Performs Source Data Review (SDR), Case Report Form (CRF) review and Source Data Verification (SDV), in accordance with the Monitoring Plan. Performs regular Site Quality Risk Assessments and adapts monitoring intensity accordingly during the study. Ensures data entry and data query resolution in a timely manner. Works with data management to ensure robust quality of the collected study data. Ensures accurate and timely reporting of Serious Adverse Events and their follow ups. Prepares and finalises monitoring visit reports in CTMS and provides timely feed-back to the Principal Investigator, including follow-up letter, within required timelines and in line with AZ SOP. Follows up on outstanding actions with study sites to ensure resolution in a timely manner. Follows quality issue processes by escalating systematic or serious quality issues, data privacy breaches, CSP or ICH-GCP compliance issues to Local Management and/or CQM as required. Assists site in maintaining inspection ready ISF. Prepares for and collaborates with the activities associated with audits and regulatory inspections in liaison with LSAD and CQAD. Ensures timely collection/uploading of essential documents into the eTMF in accordance with ICH-GCP, AZ SOPs and local requirements. Supports/participates in regular QC checks performed by LSAD or delegate. Ensures that all study documents under their responsibility (i.e. site documents, relevant communications, etc) are available and ready for final archiving and completion of local part of the eTMF. Provides feedback on any research related information including sites/investigators/competing studies that might be useful for the local market. Ensures compliance with AstraZeneca's Code of Ethics, company policies and procedures relating to


people, finance, technology, security and SHE (Safety, Health and Environment). Ensures compliance with local, national and regional legislation, as applicable. Collaborates with local stakeholders for site study delivery (eg MSLs, Site Engagement Lead where applicable). Identify issues at sites; resolve issues and escalate as appropriate involving local stakeholders and LSADs Support the implementation of innovative processes and technologies

Why AstraZeneca?

At AstraZeneca we're dedicated to being a Great Place to Work. Where you are empowered to push the boundaries of science and unleash your entrepreneurial spirit. There's no better place to make a difference to medicine, patients and society. An inclusive culture that champions diversity and collaboration, and always committed to lifelong learning, growth and development. We're on an exciting journey to pioneer the future of healthcare.